Chromium

Evidence Level
Moderate
5 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

Chromium is an essential trace mineral that plays a key role in regulating blood sugar by enhancing the effects of insulin, making it important for carbohydrate and fat metabolism. It is naturally found in small amounts in foods such as whole grains, broccoli, green beans, meat, poultry, nuts, and eggs. True dietary deficiency has essentially never been documented in healthy people, so most people are not short of it. Supplements are sold widely anyway, usually at doses far above what food provides. Common supplemental forms include chromium picolinate, chromium polynicotinate, and chromium chloride, with chromium picolinate being the most widely used in blood sugar support formulas.

Studied Dose 25–35 mcg/day (AI); blood sugar studies used 200–1,000 mcg/day chromium picolinate in people with diagnosed type 2 diabetes rather than healthy adults.
Active Compound Chromium Picolinate / Chromium Polynicotinate
Deficiency information View details

Chromium's status as an essential nutrient is debated, and isolated dietary deficiency has never been definitively documented in healthy people. The few documented cases were patients on long-term TPN who developed insulin resistance reversed by chromium supplementation. Chromium is sold heavily as a 'blood sugar' supplement, but evidence for benefit in non-deficient people is weak.

Common symptoms

  • Documented chromium deficiency in humans is extremely rare and limited to TPN cases
  • Insulin resistance, impaired glucose tolerance
  • Unexplained weight loss
  • Confusion or impaired cognition
  • Peripheral neuropathy
  • Note: blood sugar issues in the general population almost always have causes other than chromium status

At-risk groups

  • People on long-term parenteral nutrition without chromium (only documented cases)
  • Note: insulin resistance, prediabetes, and type 2 diabetes are NOT chromium deficiency states
  • There are no validated lab tests reliably indicating chromium deficiency in the general population
When to see a doctor: If you have blood sugar concerns, insulin resistance, or diabetes, the evidence-based interventions are diet, exercise, weight management, and (when needed) metformin or other prescribed medications — NOT chromium supplements. The 2020 meta-analysis cited on this page did find modest improvements in blood sugar markers in people with type 2 diabetes, and its authors said the results might support chromium use. Even so, chromium is at most an addition to medical care, never a replacement for it. If you have actual symptoms of insulin resistance, see a doctor for proper evaluation.

Benefits

Blood Sugar Regulation

The one study cited on this page is a 2020 systematic review that pooled 28 randomized trials, and every participant in it had diagnosed type 2 diabetes. In that pooled analysis chromium lowered fasting plasma glucose by about 19 mg/dl, HbA1c by about 0.71 percentage points, fasting insulin by about 12 pmol/l and a measure of insulin resistance called HOMA-IR by about 1.53. The authors worded their own conclusion cautiously, saying the results might support chromium use for blood sugar control in people with type 2 diabetes. That is research in people who already have a diagnosed disease, so it does not show what chromium does for a healthy person's blood sugar, and chromium is not a treatment for diabetes. If you take insulin or any other glucose-lowering medication, talk to your doctor first, because adding something that lowers blood sugar on top of medication that lowers blood sugar can push you too low.

Metabolism Support

Chromium is involved in how the body handles carbohydrates and fats through its effect on insulin signaling. That is textbook nutrition biochemistry rather than a measured benefit: no study cited on this page measured energy use, metabolic rate or nutrient handling in people.

Weight Management

Chromium is heavily marketed for weight loss and appetite control, but nothing cited on this page supports that. The single reference here looked only at blood sugar markers in people with type 2 diabetes and did not measure body weight, body fat or appetite at all.

Cholesterol Levels

No study cited on this page measured cholesterol. The single reference here reviewed blood sugar outcomes in people with type 2 diabetes, so this page has nothing to support a cholesterol or heart health benefit.

Polycystic Ovary Syndrome (PCOS)

Nothing cited on this page addresses polycystic ovary syndrome. The single reference here enrolled people with type 2 diabetes and reported blood sugar markers only. PCOS is a medical condition that needs a doctor, and no supplement should be presented as a treatment for it.

Mechanism of action

1

Insulin Sensitization

The proposed mechanism is that chromium supports insulin signaling and helps move the glucose transporter GLUT4 to the cell surface, which would improve glucose uptake. This comes from laboratory work, not from the human study cited on this page.

2

Metabolic Regulation

Chromium is thought to form part of a molecule called chromodulin, which may amplify insulin’s effects on carbohydrate, fat, and protein metabolism.

3

Lipid Metabolism

One proposed mechanism is that chromium influences enzymes involved in cholesterol production. This is theory only, and no cholesterol result is reported in the single study cited on this page.

Clinical trials

1
Chromium Picolinate and Cardiometabolic Biomarkers in T2DM — Clinical Trial

Randomized controlled trial of chromium picolinate (200 µg/day) vs placebo in 52 T2DM patients over 12 weeks. Outcomes: fasting glucose, HbA1c, lipid profile, insulin resistance. (Clin Nutr Res)

52 T2DM patients. 12-week intervention.

This trial is not among the references listed on this page, so its numbers cannot be verified here. What the page can actually support comes from its one reference, a 2020 pooled analysis of 28 randomized trials in people with type 2 diabetes, which reported lower fasting glucose and HbA1c but did not report cholesterol outcomes at all. The lipid claim in this card is therefore unverified, and any effect described here was seen in people with a diagnosed disease, not in healthy adults.

2
Chromium-Enriched Yeast in Insulin-Treated T2DM — Clinical Trial

Randomized controlled trial of chromium-enriched yeast (400 µg/day chromium) vs placebo in 36 insulin-treated T2DM patients over 12 weeks. Outcomes: fasting plasma glucose, HbA1c, insulin requirements, lipid profile.

36 insulin-treated T2DM patients.

This trial is not among the references listed on this page, so its results cannot be verified here. It was also very small, 36 people. Nothing cited here compares chromium-enriched yeast head to head against chromium picolinate, so the suggestion that one form is better than the other is not supported. Anyone using insulin should never adjust their dose because of a supplement without their doctor.

3
Chromium and Cardiometabolic Risk — Dose-Response Evidence Synthesis

Pooled analysis of 23 clinical trials examining chromium supplementation effects on cardiometabolic outcomes (glucose, HbA1c, lipids, blood pressure) with a dose-response analysis. (Wan et al. 2023, JACC Adv) This analysis is not among the references listed on this page, so it could not be verified here.

Pooled across 23 clinical trials.

In T2DM patients, chromium doses ≥400 µg/day significantly reduced fasting plasma glucose (WMD: -0.67 mmol/L) and HbA1c. Lower doses showed minimal effects, and in people without diabetes the effects were not statistically significant. That null result matters: it means the pattern here matches the one study this page does cite, where the benefit was seen in people with diagnosed type 2 diabetes and not in healthy people. Because this analysis is not among the page's references, its specific numbers cannot be checked here.

4
Chromium and Blood Pressure — Evidence Synthesis

Evidence review and pooled analysis of 11 clinical trials through assessing chromium supplementation effects on systolic and diastolic blood pressure. (Eur J Clin Nutr)

Pooled across 11 clinical trials.

This is a null result: no meaningful effect on systolic or diastolic blood pressure overall. Chromium should not be taken for blood pressure. A subgroup hint inside an otherwise negative analysis is a hypothesis, not a finding. This review is also not among the references listed on this page, so it could not be verified here.

5
Chromium and Cognition in Older Adults with Memory Decline — Clinical Trial

Randomized controlled trial in 26 older adults (mean age ~65) with early memory decline receiving chromium picolinate (1,000 µg/day) vs placebo for 12 weeks. fMRI imaging and cognitive testing. (Nutr Neurosci)

26 older adults with early memory decline. 12-week intervention.

This trial is not among the references listed on this page, so it could not be verified here. It was also very small, just 26 people, it was run in older adults who already had memory decline rather than in healthy people, and it has not been repeated. It is not a reason to take chromium for memory, and no cited evidence on this page supports a brain or cognition benefit.

Side effects and drug interactions

Common Potential side effects

Gastrointestinal Issues: Common side effects include nausea, stomach irritation, vomiting, or diarrhea, especially at higher doses (e.g., above 1,000 mcg/day) or when taken on an empty stomach. Some users report abdominal pain or bloating.
Headaches and Dizziness: Mild headaches or dizziness may occur, potentially due to chromium’s effects on blood sugar or blood pressure, particularly in sensitive individuals.
Allergic Reactions: Rare allergic reactions, such as skin rash, itching, or swelling, may occur, particularly with chromium picolinate. Severe allergic reactions (e.g., anaphylaxis) are extremely rare but possible.
Blood Sugar Changes: Chromium may lower blood sugar, which can cause hypoglycemia (low blood sugar) symptoms like shakiness, sweating, or confusion, especially in people with diabetes or those taking insulin or other glucose-lowering medications.
Kidney and Liver Concerns: High doses (e.g., >1,000 mcg/day) or long-term use may rarely cause kidney or liver damage, with case reports linking chromium picolinate to kidney dysfunction or elevated liver enzymes. Individuals with pre-existing kidney or liver conditions should avoid high doses.
Mood and Sleep Disturbances: Some users report mood changes, irritability, or insomnia, though these are uncommon and not well-documented.

Important Drug interactions

Antidiabetic medications (metformin, insulin, sulfonylureas) — chromium can lower blood sugar, so combining it with glucose-lowering medication risks hypoglycemia; do not start it without talking to your doctor, and monitor blood sugar closely
NSAIDs (aspirin, ibuprofen) — may increase chromium absorption; monitor chromium levels with long-term NSAID use
Antacids and H2 blockers — reduce chromium absorption; take chromium supplement separately from antacids by 2 hours
Thyroid medications — chromium may interfere with levothyroxine absorption; separate by 3–4 hours

Frequently asked questions about Chromium

How much chromium should I take?

Supplements commonly provide 200 to 1,000 mcg per day, often as chromium picolinate. The adequate intake from diet is only about 25 to 35 mcg, so supplements far exceed baseline needs, and most blood sugar studies use 200 to 1,000 mcg. Those studies were run in people with type 2 diabetes, so there is no established supplement dose for a healthy person, and anyone on diabetes medication should involve their doctor before starting.

What is chromium used for?

Chromium is a trace mineral involved in how insulin works. The research cited on this page is about blood sugar markers in people who have type 2 diabetes. It is also sold for appetite, cravings and weight loss, but nothing cited here tested any of those. Chromium picolinate is the most common supplemental form.

Does chromium help with blood sugar or weight?

The strongest evidence on this page is a 2020 pooled analysis of 28 randomized trials in people with diagnosed type 2 diabetes, where chromium modestly lowered fasting glucose and HbA1c. Even those authors said the results might support its use rather than saying they settled the question. There is nothing cited here on weight, body fat, appetite or cravings, and nothing showing a benefit in healthy people. Diet, exercise, weight management and prescribed medication remain the evidence-based approach to blood sugar.

Is chromium safe?

Chromium picolinate is generally well tolerated at typical doses. Very high intakes have occasionally been linked to side effects, including rare case reports of kidney and liver problems. The interaction that matters most is with diabetes medication: chromium can lower blood sugar, so combining it with insulin or other glucose-lowering drugs can push blood sugar too low. It may also interfere with thyroid medication. Talk to your doctor before starting it if you take either.

What is Chromium?

Chromium is an essential trace mineral that plays a key role in regulating blood sugar by enhancing the effects of insulin, making it important for carbohydrate and fat metabolism. It is naturally found in small amounts in foods such as whole grains, broccoli, green beans, meat, poultry, nuts, and eggs.

What are the signs of Chromium deficiency?

Chromium's status as an essential nutrient is debated, and isolated dietary deficiency has never been definitively documented in healthy people. The few documented cases were patients on long-term TPN who developed insulin resistance reversed by chromium supplementation.

What is the recommended dosage of Chromium?

The clinically studied dose is 25–35 mcg/day (AI); blood sugar studies used 200–1,000 mcg/day chromium picolinate in people with diagnosed type 2 diabetes rather than healthy adults. Always follow the product label and check with a healthcare provider for personal advice.

Is Chromium safe, and does it have side effects?

For most healthy adults, Chromium is well tolerated at studied doses. Reported effects can include: Gastrointestinal Issues: Common side effects include nausea, stomach irritation, vomiting, or diarrhea, especially at higher doses (e.g., above 1,000 mcg/day) or when taken on an empty stomach. Some users report abdominal pain or bloating. It may also interact with some medications. Chromium is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Chromium interact with any medications?

Possible interactions include: Antidiabetic medications (metformin, insulin, sulfonylureas) — chromium can lower blood sugar, so combining it with glucose-lowering medication risks hypoglycemia; do not start it without talking to your doctor, and monitor blood sugar closely NSAIDs (aspirin, ibuprofen) — may in… If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Chromium?

NutraSmarts rates the evidence for Chromium as Moderate (3 out of 5). It is backed by 5 clinical trials and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Asbaghi O, Fatemeh N, Mahnaz RK, et al. Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2020;161:105098..PubMedUsed to support: Systematic review and meta-analysis of 28 randomized trials in people with type 2 diabetes. Chromium lowered fasting plasma glucose by 19.00 mg/dl, fasting insulin by 12.35 pmol/l, HbA1c by 0.71 percentage points and HOMA-IR by 1.53. The authors concluded the results might support chromium use for blood sugar control in these patients. All participants had diagnosed diabetes; no weight, body fat or appetite outcome was measured.